{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:57:09Z","timestamp":1792515429121,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.semarthrit.2020.04.005","type":"journal-article","created":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T19:10:50Z","timestamp":1589656250000},"page":"598-607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Incident diabetes associated with hydroxychloroquine, methotrexate, biologics and glucocorticoids in rheumatoid arthritis: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"50","author":[{"given":"Wenhui","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LanLan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2020.04.005_bib0001","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1136\/annrheumdis-2011-200726","article-title":"Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"71","author":"Avina-Zubieta","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0002","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/ard.2010.141523","article-title":"Remission is the goal for cardiovascular risk management in patients with rheumatoid arthritis: a cross-sectional comparative study","volume":"70","author":"Provan","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 1","key":"10.1016\/j.semarthrit.2020.04.005_bib0003","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/S0140-6736(15)60401-9","article-title":"Type 2 diabetes and incidence of a wide range of cardiovascular diseases: a cohort study in 1.9 million people","volume":"385","author":"Dinesh Shah","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0004","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2213-8587(14)70219-0","article-title":"Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people","volume":"3","author":"Shah","year":"2015","journal-title":"Lancet Diabet Endocrinol"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117952","article-title":"The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"10","author":"Baghdadi","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0006","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1136\/ard.2009.125476","article-title":"Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis","volume":"69","author":"Solomon","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0007","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/rheumatology\/ket343","article-title":"Diabetes incidence in psoriatic arthritis, psoriasis and rheumatoid arthritis: a UK population-based cohort study","volume":"53","author":"Dubreuil","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0008","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/acr.23171","article-title":"Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis","volume":"69","author":"Radner","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0009","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/rheumatology\/kex414","article-title":"High prevalence of diabetes in patients with rheumatoid arthritis: results from a questionnaire survey linked to claims data","volume":"57","author":"Albrecht","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0010","first-page":"1403","article-title":"Inflammation, insulin resistance, and aberrant lipid metabolism as cardiovascular risk factors in rheumatoid arthritis","volume":"30","author":"Dessein","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0011","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1002\/art.23600","article-title":"Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms","volume":"58","author":"Chung","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0012","doi-asserted-by":"crossref","first-page":"e14328","DOI":"10.1371\/journal.pone.0014328","article-title":"Effects of inhibition of interleukin-6 signalling on insulin sensitivity and lipoprotein levels in human subjects with rheumatoid diseases","volume":"5","author":"Schultz","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0013","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s10067-007-0539-8","article-title":"Impact of TNF inhibition on insulin resistance and lipids levels in patients with rheumatoid arthritis","volume":"26","author":"Tam","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0014","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jama.286.3.327","article-title":"C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus","volume":"286","author":"Pradhan","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0015","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2337\/diabetes.53.3.693","article-title":"Inflammatory markers and risk of developing type 2 diabetes in women","volume":"53","author":"Hu","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0016","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cyto.2016.06.028","article-title":"Adiponectin, TNF-\u03b1 and inflammatory cytokines and risk of type 2 diabetes: a systematic review and meta-analysis","volume":"86","author":"Liu","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0017","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/annrheumdis-2016-209954","article-title":"Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis","volume":"76","author":"Ozen","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0018","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jama.298.2.187","article-title":"Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis","volume":"298","author":"Wasko","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0019","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1001\/jama.2011.878","article-title":"Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis","volume":"305","author":"Solomon","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0020","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1002\/art.27703","article-title":"Changes in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexate treatment in diabetes patients with rheumatic diseases","volume":"62","author":"Rekedal","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0021","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/acr.20657","article-title":"Diabetes mellitus risk in rheumatoid arthritis: reduced incidence with anti-tumor necrosis factor \u03b1 therapy","volume":"64","author":"Antohe","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0022","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1002\/art.39537","article-title":"Risk of incident diabetes associated with dose and duration of oral glucocorticoid therapy in patients with rheumatoid arthritis","volume":"68","author":"Movahedi","year":"2016","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0023","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1136\/ard.2010.132845","article-title":"Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab","volume":"70","author":"Ogata","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clim.2018.07.003","article-title":"Hydroxychloroquine efficiently suppresses inflammatory responses of human class-switched memory B cells via Toll-like receptor 9 inhibition","volume":"195","author":"Torigoe","year":"2018","journal-title":"Clin Immunol"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0025","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jsbmb.2018.08.010","article-title":"Glucocorticoid-induced insulin resistance is related to macrophage visceral adipose tissue infiltration","volume":"185","author":"Do","year":"2019","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210459","article-title":"Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis","volume":"14","author":"Lillegraven","year":"2019","journal-title":"PLoS ONE"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0027","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2147\/TCRM.S130666","article-title":"Association between use of disease-modifying antirheumatic drugs and diabetes in patients with ankylosing spondylitis, rheumatoid arthritis, or psoriasis\/psoriatic arthritis: a nationwide, population-based cohort study of 84,989 patients","volume":"13","author":"Chen","year":"2017","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0028","first-page":"1151","article-title":"Risk of diabetes mellitus in rheumatoid arthritis associated with medications used in RA: a population based cohort study","volume":"43","author":"Schmidt","year":"2016","journal-title":"Journal of Rheumatology"},{"issue":"suppl10","key":"10.1016\/j.semarthrit.2020.04.005_bib0029","article-title":"Disease Activity, Cytokine Profiles, and the Risk of Incident Diabetes in Rheumatoid Arthritis [abstract]","volume":"71","author":"Baker","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0030","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/annrheumdis-2012-eular.2574","article-title":"FRI0117 Diabetes in rheumatoid arthritis: incidence and association with RA treatment","volume":"71","author":"Holmqvist","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0031","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0032","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0033","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/RHU.0b013e318214b6b5","article-title":"Hydroxychloroquine use and decreased risk of diabetes in rheumatoid arthritis patients","volume":"17","author":"Bili","year":"2011","journal-title":"J Clin Rheumatol"},{"issue":"Suppl 3","key":"10.1016\/j.semarthrit.2020.04.005_bib0034","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1136\/annrheumdis-2017-eular.5222","article-title":"THU0167 Association of biologic antirheumatic therapy with the risk of developing type 2 diabetes in adults with rheumatoid arthritis: new evidence from real world data","volume":"76","author":"Paul","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 9","key":"10.1016\/j.semarthrit.2020.04.005_bib0035","first-page":"1696","article-title":"Comparative risk of diabetes mellitus in rheumatoid arthritis patients treated with different biologics-a cohort study","volume":"70","author":"Desai","year":"2018","journal-title":"Arthritis Rheum"},{"issue":"Suppl 2","key":"10.1016\/j.semarthrit.2020.04.005_bib0036","first-page":"266","article-title":"Risk of diabetes mellitus among rheumatoid arthritis patients taking TNF inhibitors with or without non-biologic DMARDs and corticosteroid: a population-based cohort study","volume":"27","author":"Rahme","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"Suppl 2","key":"10.1016\/j.semarthrit.2020.04.005_bib0037","first-page":"266","article-title":"Risk of diabetes mellitus among rheumatoid arthritis patients taking nonbiologic DMARDS: a population-based study","volume":"27","author":"Rahme","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0038","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1136\/annrheumdis-2017-211836","article-title":"Metabolic and cardiovascular benefits of hydroxychloroquine in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"77","author":"Rempenault","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0039","doi-asserted-by":"crossref","first-page":"R135","DOI":"10.1186\/ar3868","article-title":"Hydroxychloroquine improves insulin sensitivity in obese non-diabetic individuals","volume":"14","author":"Mercer","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0040","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1007\/s00125-015-3689-2","article-title":"Antidiabetogenic effects of hydroxychloroquine on insulin sensitivity and beta cell function: a randomised trial","volume":"58","author":"Wasko","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0041","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/acr.22285","article-title":"Effect of hydroxychloroquine on insulin sensitivity and lipid parameters in rheumatoid arthritis patients without diabetes mellitus: a randomized, blinded crossover trial","volume":"66","author":"Solomon","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"Suppl 9","key":"10.1016\/j.semarthrit.2020.04.005_bib0042","first-page":"1714","article-title":"Favorable effect of hydroxychloroquine in patients with rheumatoid arthritis and diabetes or impaired glucose control","volume":"70","author":"Polara","year":"2018","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0043","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1002\/art.27703","article-title":"Changes in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexate treatment in diabetes patients with rheumatic diseases","volume":"62","author":"Rekedal","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0044","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/art.38652","article-title":"Effect of methotrexate use and erythrocyte methotrexate polyglutamate on glycosylated hemoglobin in rheumatoid arthritis","volume":"66","author":"de Rotte","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196368","article-title":"Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study","volume":"13","author":"Otsuka","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0046","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002901","article-title":"Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): a multicentre, open-label, randomised controlled trial","volume":"16","author":"Ruscitti","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.semarthrit.2020.04.005_bib0047","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1136\/ard.2010.132845","article-title":"Improvement of HbA1c during treatment with humanised anti-interleukin 6 receptor antibody, tocilizumab","volume":"70","author":"Ogata","year":"2011","journal-title":"Ann Rheum Dis"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017220301013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017220301013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:01:51Z","timestamp":1758733311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017220301013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0049017220301013"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.04.005","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incident diabetes associated with hydroxychloroquine, methotrexate, biologics and glucocorticoids in rheumatoid arthritis: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}